← FDA Drug Approvals (Drugs@FDA)
SECUADO
NDA · New Drug Application · Sponsor: HISAMITSU · Approved 2019-10-11
Drug application
- FDA Application #
NDA212268- Application type
- New Drug Application
- Brand name
- SECUADO
- Generic name
- ASENAPINE
- Active ingredients
- ASENAPINE
- Dosage form
- SYSTEM
- Route
- TRANSDERMAL
- Marketing status
- Prescription
- Sponsor
- HISAMITSU
- Manufacturer
- Noven Therapeutics, LLC
- First approval
- 2019-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown